NCT02681237 A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer Status COMPLETED Phase NA
NCT02681094 A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02679729 To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose Administration Status COMPLETED Phase PHASE1
NCT02678182 Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02677038 Olaparib in Treating Patients With Stage IV Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02675530 Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism Status COMPLETED Phase PHASE1
NCT02670642 Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD Status COMPLETED Phase PHASE3
NCT02669914 MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors Status TERMINATED Phase PHASE2
NCT02668185 Neuropeptide Treatment for Hot Flushes During the Menopause Status COMPLETED Phase PHASE2
NCT02664935 National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02663713 A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction Status COMPLETED Phase PHASE4
NCT02663128 A Study of Lanabecestat (LY3314814) in Healthy Participants Status COMPLETED Phase PHASE1
NCT02658214 Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02653872 A Phase I Study to Assess PK of AZD7986 Alone & With Verapamil, Itraconazole or Diltiazem in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02649686 Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab Status COMPLETED Phase PHASE1
NCT02648438 A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02645253 A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men Status COMPLETED Phase PHASE1
NCT02643550 Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1/PHASE2
NCT02640755 Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase Status COMPLETED Phase PHASE1